Vaccination of gallinaceous poultry for H5N1 highly pathogenic avian influenza: Current questions and new technology

Virus Research

Volumn 178, Issue 1, 2013, Pages 121-132

  Spackman, Erica ^a   Swayne, David E ^a  

^a AGRICULTURAL RESEARCH SERVICE   (United States)

Author keywords

Avian influenza virus vaccination; H5N1 high pathogenicity avian influenza virus; Poultry vaccination

Indexed keywords

ADENOVIRUS VECTOR; AVIAN INFLUENZA VACCINE; DNA VACCINE; INACTIVATED VIRUS VACCINE; INFLUENZA VACCINE; LIVE VACCINE; MATERNAL ANTIBODY; SUBUNIT VACCINE;

AMINO ACID SEQUENCE; ANALYTIC METHOD; ANTIBODY TITER; ANTIGENIC CARTOGRAPHY; ANTIGENIC VARIATION; ARTICLE; AVIAN INFLUENZA; AVIAN INFLUENZA VIRUS; BANGLADESH; CHICKEN; CHICKEN MEAT; CHINA; DRUG EFFECT; DRUG EFFICACY; EGYPT; FOWLPOX VIRUS; HERD IMMUNITY; HERPES VIRUS; HONG KONG; ILTOVIRUS; IMMUNE RESPONSE; INDIA; INDONESIA; INFECTION CONTROL; INFLUENZA VACCINATION; INFLUENZA VIRUS A H5N1; NEWCASTLE DISEASE PARAMYXOVIRUS; NONHUMAN; POULTRY; PRIORITY JOURNAL; REVERSE GENETICS; SEASONAL INFLUENZA; TURKEY (BIRD); VACCINE PRODUCTION; VIET NAM;

AVES; AVIAN INFLUENZA VIRUS;

AVIAN INFLUENZA VIRUS VACCINATION; H5N1 HIGH PATHOGENICITY AVIAN INFLUENZA VIRUS; POULTRY VACCINATION;

ANIMALS; INFLUENZA A VIRUS, H5N1 SUBTYPE; INFLUENZA IN BIRDS; INFLUENZA VACCINES; POULTRY; POULTRY DISEASES; VACCINATION;

EID: 84887626274     PISSN: 01681702     EISSN: 18727492     Source Type: Journal    
DOI: 10.1016/j.virusres.2013.03.004     Document Type: Article

References (132)

1. Abbas M.A., Spackman E., Fouchier R., Smith D., Ahmed Z., Siddique N., Sarmento L., Naeem K., McKinley E.T., Hameed A., Rehmani S., Swayne D.E. H7 avian influenza virus vaccines protect chickens against challenge with antigenically diverse isolates. Vaccine 2011, 29(43):7424-7429.
2. Abdel-Moneim A.S., Afifi M.A., El-Kady M.F. Genetic drift evolution under vaccination pressure among H5N1 Egyptian isolates. Virology Journal 2011, 8:283.
3. Abdelwhab E.M., Grund C., Aly M.M., Beer M., Harder T.C., Hafez H.M. Multiple dose vaccination with heterologous H5N2 vaccine: immune response and protection against variant clade 2.2.1 highly pathogenic avian influenza H5N1 in broiler breeder chickens. Vaccine 2011, 29(37):6219-6225.
4. Abdelwhab E.M., Grund C., Aly M.M., Beer M., Harder T.C., Hafez H.M. Influence of maternal immunity on vaccine efficacy and susceptibility of one day old chicks against Egyptian highly pathogenic avian influenza H5N1. Veterinary Microbiology 2012, 155(1):13-20.
5. Abt M., de Jonge J., Laue M., Wolff T. Improvement of H5N1 influenza vaccine viruses: influence of internal gene segments of avian and human origin on production and hemagglutinin content. Vaccine 2011, 29(32):5153-5162.
6. Archetti I., Horsfall F.L. Persistent antigenic variation of influenza A viruses after incomplete neutralization in ovo with heterologous immune serum. Journal of Experimental Medicine 1950, 92(5):441-462.
7. Beard C.W., Schnitzlein W.M., Tripathy D.N. Effect of route of administration on the efficacy of a recombinant fowlpox virus against H5N2 avian influenza. Avian Diseases 1992, 36(4):1052-1055.
8. Boltz D.A., Douangngeun B., Sinthasak S., Phommachanh P., Midouangchanh P., Walker D., Keating R., Khalenkov A.M., Kumar M., Webster R.G. Field assessment of an H5N1 inactivated vaccine in chickens and ducks in Lao PDR. Archives of Virology 2009, 154(6):939-944.
9. Bouma A., Muljono A.T., Jatikusumah A., Nell A.J., Mudjiartiningsih S., Dharmayanti I., Siregar E.S., Claassen I., Koch G., Stegeman J.A. Field trial for assessment of avian influenza vaccination effectiveness in Indonesia. Revue Scientifique et Technique 2008, 27(3):633-642.
10. Bouma A., Claassen I., Natih K., Klinkenberg D., Donnelly C.A., Koch G., van Boven M. Estimation of transmission parameters of H5N1 avian influenza virus in chickens. PLoS Pathogen 2009, 5(1):e1000281.
11. Box P.G. The influence of maternal antibody on vaccination against Newcastle disease. Veterinary Record 1965, 77:246-250.
12. Boyle D.B., Selleck P., Heine H.G. Vaccinating chickens against avian influenza with fowlpox recombinants expressing the H7 haemagglutinin. Australian Veterinary Journal 2000, 78(1):44-48.
13. Bublot M., Pritchard N., Swayne D.E., Selleck P., Karaca K., Suarez D.L., Audonnet J.C., Mickle T.R. Development and use of fowlpox vectored vaccines for avian influenza. Annals of the New York Academy of Sciences 2006, 1081:193-201.
14. Bublot M., Pritchard N., Cruz J.S., Mickle T.R., Selleck P., Swayne D.E. Efficacy of a fowlpox-vectored avian influenza H5 vaccine against Asian H5N1 highly pathogenic avian influenza virus challenge. Avian Diseases 2007, 51(Suppl. 1):498-500.
15. Cai Z., Zhang T., Wan X.F. A computational framework for influenza antigenic cartography. PLoS Computers in Biology 2010, 6(10):e1000949.
16. Capua I., Terregino C., Cattoli G., Toffan A. Increased resistance of vaccinated turkeys to experimental infection with an H7N3 low-pathogenicity avian influenza virus. Avian Pathology 2004, 33(2):158-163.
17. Cattoli G., Fusaro A., Monne I., Coven F., Joannis T., El-Hamid H.S., Hussein A.A., Cornelius C., Amarin N.M., Mancin M., Holmes E.C., Capua I. Evidence for differing evolutionary dynamics of A/H5N1 viruses among countries applying or not applying avian influenza vaccination in poultry. Vaccine 2011, 29(50):9368-9375.
18. Chen H. Avian influenza vaccination: the experience in China. Revue Scientifique et Technique 2009, 28(1):267-274.
19. Chen H.Y., Shang Y.H., Yao H.X., Cui B.A., Zhang H.Y., Wang Z.X., Wang Y.D., Chao A.J., Duan T.Y. Immune responses of chickens inoculated with a recombinant fowlpox vaccine coexpressing HA of H9N2 avain influenza virus and chicken IL-18. Antiviral Research 2011, 91(1):50-56.
20. Corti D., Voss J., Gamblin S.J., Codoni G., Macagno A., Jarrossay D., Vachieri S.G., Pinna D., Minola A., Vanzetta F., Silacci C., Fernandez-Rodriguez B.M., Agatic G., Bianchi S., Giacchetto-Sasselli I., Calder L., Sallusto F., Collins P., Haire L.F., Temperton N., Langedijk J.P.M., Skehel J.J., Lanzavecchia A. A neutralizing antibody selected from plasma cells that binds to group 1 and group 2 influenza A hemagglutinins. Science 2011, 333(6044):850-856.
21. Coussens P.M., Smith K.A., Weber P.S., Colvin C.J. Immortalized chick embryo cell line adapted to serum-free growth conditions and capable of replicating human and reassortant H5N1 influenza strains for vaccine production. Vaccine 2011, 29(47):8661-8668.
22. D'Aoust M.A., Couture M.M., Charland N., Trepanier S., Landry N., Ors F., Vezina L.P. The production of hemagglutinin-based virus-like particles in plants: a rapid, efficient and safe response to pandemic influenza. Plant Biotechnology Journal 2010, 8(5):607-619.
23. Davenport F.M., Hennessy A.V., Maassab H.F., Minuse E., Clark L.C., Abrams G.D., Mitchell J.R. Pilot studies on recombinant cold-adapted live type A and B influenza virus vaccines. Journal of Infectious Diseases 1977, 136(1):17-25.
24. de Jong J.C., Smith D.J., Lapedes A.S., Donatelli I., Campitelli L., Barigazzi G., Van Reeth K., Jones T.C., Rimmelzwaan G.F., Osterhaus A.D., Fouchier R.A. Antigenic and genetic evolution of swine influenza A (H3N2) viruses in Europe. Journal of Virology 2007, 81(8):4315-4322.
25. Eggert D., Swayne D.E. Single vaccination provides limited protection to ducks and geese against H5N1 high pathogenicity avian influenza virus. Avian Diseases 2010, 54(4):1224-1229.
26. Eggert D., Thomas C., Spackman E., Pritchard N., Rojo F., Bublot M., Swayne D.E. Characterization and efficacy determination of commercially available Central American H5N2 avian influenza vaccines for poultry. Vaccine 2010, 28(29):4609-4615.
27. Egypt, G.o., 2010. Intergrated National Plan for Avian and Human Influenza: Avian Health and Livelihood Sustainability Strategy.
28. Ekiert D.C., Friesen R.H.E., Bhabha G., Kwaks T., Jongeneelen M., Yu W., Ophorst C., Cox F., Korse H.J.W.M., Brandenburg B., Vogels R., Brakenhoff J.P.J., Kompier R., Koldijk M.H., Cornelissen L.A.H.M., Poon L.L.M., Peiris M., Koudstaal W., Wilson I.A., Goudsmit J. A highly conserved neutralizing epitope on group 2 influenza A viruses. Science 2011, 333(6044):843-850.
29. Elbers A.R., Fabri T.H., de Vries T.S., de Wit J.J., Pijpers A., Koch G. The highly pathogenic avian influenza A (H7N7) virus epidemic in The Netherlands in 2003 - lessons learned from the first five outbreaks. Avian Diseases 2004, 48(3):691-705.
30. Ellis T.M., Leung C.Y., Chow M.K., Bissett L.A., Wong W., Guan Y., Malik Peiris J.S. Vaccination of chickens against H5N1 avian influenza in the face of an outbreak interrupts virus transmission. Avian Pathology 2004, 33(4):405-412.
31. Epstein S.L., Tumpey T.M., Misplon J.A., Lo C.Y., Cooper L.A., Subbarao K., Renshaw M., Sambhara S., Katz J.M. DNA vaccine expressing conserved influenza virus proteins protective against H5N1 challenge infection in mice. Emerging Infectious Diseases 2002, 8(8):796-801.
32. Escorcia M., Vazquez L., Mendez S.T., Rodriguez-Ropon A., Lucio E., Nava G.M. Avian influenza: genetic evolution under vaccination pressure. Virology Journal 2008, 5:15.
33. Fouchier R.A., Smith D.J. Use of antigenic cartography in vaccine seed strain selection. Avian Diseases 2010, 54(Suppl. 1):220-223.
34. Gao W., Soloff A.C., Lu X., Montecalvo A., Nguyen D.C., Matsuoka Y., Robbins P.D., Swayne D.E., Donis R.O., Katz J.M., Barratt-Boyes S.M., Gambotto A. Protection of mice and poultry from lethal H5N1 avian influenza virus through adenovirus-based immunization. Journal of Virology 2006, 80(4):1959-1964.
35. Garcia A., Johnson H., Srivastava D.K., Jayawardene D.A., Wehr D.R., Webster R.G. Efficacy of inactivated H5N2 influenza vaccines against lethal A/Chicken/Queretaro/19/95 infection. Avian Diseases 1998, 42(2):248-256.
36. Ge J., Deng G., Wen Z., Tian G., Wang Y., Shi J., Wang X., Li Y., Hu S., Jiang Y., Yang C., Yu K., Bu Z., Chen H. Newcastle disease virus-based live attenuated vaccine completely protects chickens and mice from lethal challenge of homologous and heterologous H5N1 avian influenza viruses. Journal of Virology 2007, 81(1):150-158.
37. Ge J., Tian G., Zeng X., Jiang Y., Chen H., Bua Z. Generation and evaluation of a Newcastle disease virus-based H9 avian influenza live vaccine. Avian Diseases 2010, 54(Suppl. 1):294-296.
38. Grund C., Abdelwhab el S.M., Arafa A.S., Ziller M., Hassan M.K., Aly M.M., Hafez H.M., Harder T.C., Beer M. Highly pathogenic avian influenza virus H5N1 from Egypt escapes vaccine-induced immunity but confers clinical protection against a heterologous clade 2.2.1 Egyptian isolate. Vaccine 2011, 29(33):5567-5573.
39. Harvey R., Nicolson C., Johnson R.E., Guilfoyle K.A., Major D.L., Robertson J.S., Engelhardt O.G. Improved haemagglutinin antigen content in H5N1 candidate vaccine viruses with chimeric haemagglutinin molecules. Vaccine 2010, 28(50):8008-8014.
40. Hassan M.K., Afify M.A., Aly M.M. Genetic resistance of Egyptian chickens to infectious bursal disease and Newcastle disease. Tropical Animal Health and Production 2004, 36(1):1-9.
41. Hofstad M.S. Antigenic differences among isolates of avian infectious bronchitis virus. American Journal of Veterinary Research 1958, 19(72):740-743.
42. Hwang S.D., Kim H.S., Cho S.W., Seo S.H. Single dose of oil-adjuvanted inactivated vaccine protects chickens from lethal infections of highly pathogenic H5N1 influenza virus. Vaccine 2011, 29(11):2178-2186.
43. Isoda N., Sakoda Y., Okamatsu M., Tsuda Y., Kida H. Improvement of the H5N1 influenza virus vaccine strain to decrease the pathogenicity in chicken embryos. Archives of Virology 2011, 156(4):557-563.
44. Jiang Y., Zhang H., Wang G., Zhang P., Tian G., Bu Z., Chen H. Protective efficacy of H7 subtype avian influenza DNA vaccine. Avian Diseases 2010, 54(Suppl. 1):290-293.
45. Kapczynski D.R., Swayne D.E. Influenza vaccines for avian species. Current Topics in Microbiology and Immunology 2009, 333:133-152.
46. Kilany W.H., Abdelwhab E.M., Arafa A.S., Selim A., Safwat M., Nawar A.A., Erfan A.M., Hassan M.K., Aly M.M., Hafez H.M. Protective efficacy of H5 inactivated vaccines in meat turkey poults after challenge with Egyptian variant highly pathogenic avian influenza H5N1 virus. Veterinary Microbiology 2011, 150(1/2):28-34.
47. Kim J.K., Kayali G., Walker D., Forrest H.L., Ellebedy A.H., Griffin Y.S., Rubrum A., Bahgat M.M., Kutkat M.A., Ali M.A., Aldridge J.R., Negovetich N.J., Krauss S., Webby R.J., Webster R.G. Puzzling inefficiency of H5N1 influenza vaccines in Egyptian poultry. Proceedings of the National Academy of Sciences of the United States of America 2010, 107(24):11044-11049.
48. Kodihalli S., Goto H., Kobasa D.L., Krauss S., Kawaoka Y., Webster R.G. DNA vaccine encoding hemagglutinin provides protective immunity against H5N1 influenza virus infection in mice. Journal of Virology 1999, 73(3):2094-2098.
49. Kumar M., Chu H.J., Rodenberg J., Krauss S., Webster R.G. Association of serologic and protective responses of avian influenza vaccines in chickens. Avian Diseases 2007, 51(Suppl. 1):481-483.
50. Kwon Y.K., Swayne D.E. Different routes of inoculation impact infectivity and pathogenesis of H5N1 high pathogenicity avian influenza virus infection in chickens and domestic ducks. Avian Diseases 2010, 54(4):1260-1269.
51. Landry N., Ward B.J., Trepanier S., Montomoli E., Dargis M., Lapini G., Vezina L.P. Preclinical and clinical development of plant-made virus-like particle vaccine against avian H5N1 influenza. PLoS ONE 2010, 5(12):e15559.
52. Lapedes A.S., Farber R. The geometry of shape space: application to influenza. Journal of Theoretical Biology 2001, 212(1):57-69.
53. Lashgari M.S., Newman J.A. Serological comparison and antigenic relationships of seven serotypes of infectious bronchitis virus using the hemagglutination-inhibition test. Avian Diseases 1984, 28(2):435-443.
54. Layton S.L., Kapczynski D.R., Higgins S., Higgins J., Wolfenden A.D., Liljebjelke K.A., Bottje W.G., Swayne D., Berghman L.R., Kwon Y.M., Hargis B.M., Cole K. Vaccination of chickens with recombinant Salmonella expressing M2e and CD154 epitopes increases protection and decreases viral shedding after low pathogenic avian influenza challenge. Poultry Science 2009, 88(11):2244-2252.
55. Lee C.W., Senne D.A., Suarez D.L. Effect of vaccine use in the evolution of Mexican lineage H5N2 avian influenza virus. Journal of Virology 2004, 78(15):8372-8381.
56. Lee S.W., Markham P.F., Coppo M.J., Legione A.R., Markham J.F., Noormohammadi A.H., Browning G.F., Ficorilli N., Hartley C.A., Devlin J.M. Attenuated vaccines can recombine to form virulent field viruses. Science 2012, 337(6091):188.
57. Liljebjelke K.A., Petkov D.I., Kapczynski D.R. Mucosal vaccination with a codon-optimized hemagglutinin gene expressed by attenuated Salmonella elicits a protective immune response in chickens against highly pathogenic avian influenza. Vaccine 2010, 28(27):4430-4437.
58. Lin Y.J., Deng M.C., Wu S.H., Chen Y.L., Cheng H.C., Chang C.Y., Lee M.S., Chien M.S., Huang C.C. Baculovirus-derived hemagglutinin vaccine protects chickens from lethal homologous virus H5N1 challenge. Journal of Veterinary Medical Science 2008, 70(11):1147-1152.
59. Liu M., Wood J.M., Ellis T., Krauss S., Seiler P., Johnson C., Hoffmann E., Humberd J., Hulse D., Zhang Y., Webster R.G., Perez D.R. Preparation of a standardized, efficacious agricultural H5N3 vaccine by reverse genetics. Virology 2003, 314(2):580-590.
60. Luschow D., Werner O., Mettenleiter T.C., Fuchs W. Protection of chickens from lethal avian influenza A virus infection by live-virus vaccination with infectious laryngotracheitis virus recombinants expressing the hemagglutinin (H5) gene. Vaccine 2001, 19(30):4249-4259.
61. Maas R., Rosema S., van Zoelen D., Venema S. Maternal immunity against avian influenza H5N1 in chickens: limited protection and interference with vaccine efficacy. Avian Pathology 2011, 40(1):87-92.
62. Marangon S., Busani L., Capua I. Practicalities of the implementation of a vaccination campaign for avian influenza. Avian Diseases 2007, 51(Suppl. 1):297-303.
63. Mariner, J., 2011. Final Report: Operational Research in Indonesia for More Effective Control of Highly Pathogenic Avian Influenza. 1-154.
64. Mondal S.P., Naqi S.A. Maternal antibody to infectious bronchitis virus: its role in protection against infection and development of active immunity to vaccine. Veterinary Immunology and Immunopathology 2001, 79(1/2):31-40.
65. Naeem K., Siddique N. Use of strategic vaccination for the control of avian influenza in Pakistan. Developmental Biology (Basel) 2006, 124:145-150.
66. Nang N.T., Song B.M., Kang Y.M., Kim H.M., Kim H.S., Seo S.H. Live attenuated H5N1 vaccine with H9N2 internal genes protects chickens from infections by both Highly Pathogenic H5N1 and H9N2 Influenza Viruses. Influenza and Other Respiratory Viruses 2012, 7(2):120-131.
67. Naqi S.A., Marquez B., Sahin N. Maternal antibody and its effect on infectious bursal disease immunization. Avian Diseases 1983, 27(3):623-631.
68. Neirynck S., Deroo T., Saelens X., Vanlandschoot P., Jou W.M., Fiers W. A universal influenza A vaccine based on the extracellular domain of the M2 protein. Nature Medicine 1999, 5(10):1157-1163.
69. Nielsen O.L., Sorensen P., Hedemand J.E., Laursen S.B., Jorgensen P.H. Inflammatory response of different chicken lines and B haplotypes to infection with infectious bursal disease virus. Avian Pathology 1998, 27(2):181-189.
70. Osterholm M.T., Kelley N.S., Sommer A., Belongia E.A. Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis. Lancet Infectious Diseases 2012, 12(1):36-44.
71. Pantin-Jackwood, M.J., Suarez, D.L., Review of H5N1 vaccination in ducks. Virus Research, in press.
72. Park A.W., Daly J.M., Lewis N.S., Smith D.J., Wood J.L., Grenfell B.T. Quantifying the impact of immune escape on transmission dynamics of influenza. Science 2009, 326(5953):726-728.
73. Park K.S., Lee J., Ahn S.S., Byun Y.H., Seong B.L., Baek Y.H., Song M.S., Choi Y.K., Na Y.J., Hwang I., Sung Y.C., Lee C.G. Mucosal immunity induced by adenovirus-based H5N1 HPAI vaccine confers protection against a lethal H5N2 avian influenza virus challenge. Virology 2009, 395(2):182-189.
74. Patel A., Gray M., Li Y., Kobasa D., Yao X., Kobinger G.P. Co-administration of certain DNA vaccine combinations expressing different H5N1 influenza virus antigens can be beneficial or detrimental to immune protection. Vaccine 2012, 30(3):626-636.
75. Pavade G., Awada L., Hamilton K., Swayne D.E. The influence of economic indicators, poultry density and the performance of veterinary services on the control of high-pathogenicity avian influenza in poultry. Revue Scientifique et Technique 2011, 30(3):661-671.
76. Pavlova S.P., Veits J., Keil G.M., Mettenleiter T.C., Fuchs W. Protection of chickens against H5N1 highly pathogenic avian influenza virus infection by live vaccination with infectious laryngotracheitis virus recombinants expressing H5 hemagglutinin and N1 neuraminidase. Vaccine 2009, 27(5):773-785.
77. Pavlova S.P., Veits J., Mettenleiter T.C., Fuchs W. Live vaccination with an H5-hemagglutinin-expressing infectious laryngotracheitis virus recombinant protects chickens against different highly pathogenic avian influenza viruses of the H5 subtype. Vaccine 2009, 27(37):5085-5090.
78. Peyre M., Fusheng G., Desvaux S., Roger F. Avian influenza vaccines: a practical review in relation to their application in the field with a focus on the Asian experience. Epidemiology and Infection 2009, 137(1):1-21.
79. Peyre M., Samaha H., Makonnen Y.J., Saad A., Abd-Elnabi A., Galal S., Ettel T., Dauphin G., Lubroth J., Roger F., Domenech J. Avian influenza vaccination in Egypt: limitations of the current strategy. Journal of Molecular and Genetic Medicine 2009, 3(2):198-204.
80. Pose A.G., Gomez J.N., Sanchez A.V., Redondo A.V., Rodriguez E.R., Segui R.M., Ramos E.M., Molto M.P., Rodriguez E.S., Cordero L.R., Mallon A.R., Nordelo C.B. Subunit influenza vaccine candidate based on CD154 fused to HAH5 increases the antibody titers and cellular immune response in chickens. Veterinary Microbiology 2011, 152(3/4):328-337.
81. Qiao C.L., Yu K.Z., Jiang Y.P., Jia Y.Q., Tian G.B., Liu M., Deng G.H., Wang X.R., Meng Q.W., Tang X.Y. Protection of chickens against highly lethal H5N1 and H7N1 avian influenza viruses with a recombinant fowlpox virus co-expressing H5 haemagglutinin and N1 neuraminidase genes. Avian Pathology 2003, 32(1):25-32.
82. Qiao C., Yu K., Jiang Y., Li C., Tian G., Wang X., Chen H. Development of a recombinant fowlpox virus vector-based vaccine of H5N1 subtype avian influenza. Developmental Biology (Basel) 2006, 124:127-132.
83. Qiao C., Jiang Y., Tian G., Wang X., Li C., Xin X., Chen H., Yu K. Recombinant fowlpox virus vector-based vaccine completely protects chickens from H5N1 avian influenza virus. Antiviral Research 2009, 81(3):234-238.
84. Rao S., Kong W.P., Wei C.J., Yang Z.Y., Nason M., Styles D., DeTolla L.J., Panda A., Sorrell E.M., Song H., Wan H., Ramirez-Nieto G.C., Perez D., Nabel G.J. Multivalent HA DNA vaccination protects against highly pathogenic H5N1 avian influenza infection in chickens and mice. PLoS ONE 2008, 3(6):e2432.
85. Rao S.S., Kong W.P., Wei C.J., Van Hoeven N., Gorres J.P., Nason M., Andersen H., Tumpey T.M., Nabel G.J. Comparative efficacy of hemagglutinin, nucleoprotein, and matrix 2 protein gene-based vaccination against H5N1 influenza in mouse and ferret. PLoS ONE 2010, 5(3):e9812.
86. Rauw F., Gardin Y., Palya V., Anbari S., Gonze M., Lemaire S., van den Berg T., Lambrecht B. The positive adjuvant effect of chitosan on antigen-specific cell-mediated immunity after chickens vaccination with live Newcastle disease vaccine. Veterinary Immunology and Immunopathology 2010, 134(3/4):249-258.
87. Rauw F., Palya V., Van Borm S., Welby S., Tatar-Kis T., Gardin Y., Dorsey K.M., Aly M.M., Hassan M.K., Soliman M.A., Lambrecht B., van den Berg T. Further evidence of antigenic drift and protective efficacy afforded by a recombinant HVT-H5 vaccine against challenge with two antigenically divergent Egyptian clade 2.2.1 HPAI H5N1 strains. Vaccine 2011, 29(14):2590-2600.
88. Rojas H., Moreira R., Avalos P., Capua I., Marangon S. Avian influenza in poultry in Chile. Veterinary Record 2002, 151(6):188.
89. Romer-Oberdorfer A., Veits J., Helferich D., Mettenleiter T.C. Level of protection of chickens against highly pathogenic H5 avian influenza virus with Newcastle disease virus based live attenuated vector vaccine depends on homology of H5 sequence between vaccine and challenge virus. Vaccine 2008, 26(19):2307-2313.
90. Sasaki T., Kokumai N., Ohgitani T., Sakamoto R., Takikawa N., Lin Z., Okamatsu M., Sakoda Y., Kida H. Long lasting immunity in chickens induced by a single shot of influenza vaccine prepared from inactivated non-pathogenic H5N1 virus particles against challenge with a highly pathogenic avian influenza virus. Vaccine 2009, 27(38):5174-5177.
91. Senne D.A. Avian influenza in North and South America, 2002-2005. Avian Diseases 2007, 51(Suppl. 1):167-173.
92. Smith H.W., Cook J.K., Parsell Z.E. The experimental infection of chickens with mixtures of infectious bronchitis virus and Escherichia coli. Journal of General Virology 1985, 66(Pt. (4)):777-786.
93. Smith D.J., Lapedes A.S., de Jong J.C., Bestebroer T.M., Rimmelzwaan G.F., Osterhaus A.D.M.E., Fouchier R.A.M. Mapping the antigenic and genetic evolution of influenza virus. Science 2004, 1097211.
94. Steel J., Burmakina S.V., Thomas C., Spackman E., Garcia-Sastre A., Swayne D.E., Palese P. A combination in-ovo vaccine for avian influenza virus and Newcastle disease virus. Vaccine 2008, 26(4):522-531.
95. Steel J., Lowen A.C., Pena L., Angel M., Solorzano A., Albrecht R., Perez D.R., Garcia-Sastre A., Palese P. Live attenuated influenza viruses containing NS1 truncations as vaccine candidates against H5N1 highly pathogenic avian influenza. Journal of Virology 2009, 83(4):1742-1753.
96. Steensels M., Bublot M., Van Borm S., De Vriese J., Lambrecht B., Richard-Mazet A., Chanavat-Bizzini S., Duboeuf M., Le Gros F.X., van den Berg T. Prime-boost vaccination with a fowlpox vector and an inactivated avian influenza vaccine is highly immunogenic in Pekin ducks challenged with Asian H5N1 HPAI. Vaccine 2009, 27(5):646-654.
97. Suarez D.L. DIVA vaccination strategies for avian influenza virus. Avian Diseases 2012, 56(Suppl. 4):836-844.
98. Suarez D.L., Schultz-Cherry S. The effect of eukaryotic expression vectors and adjuvants on DNA vaccines in chickens using an avian influenza model. Avian Diseases 2000, 44(4):861-868.
99. Suarez D.L., Lee C.W., Swayne D.E. Avian influenza vaccination in North America: strategies and difficulties. Developmental Biology (Basel) 2006, 124:117-124.
100. Swayne D.E. Principles for vaccine protection in chickens and domestic waterfowl against avian influenza: emphasis on Asian H5N1 high pathogenicity avian influenza. Annals of the New York Academy of Sciences 2006, 1081:174-181.
101. Swayne D., Kapczynski D. Vaccines, vaccination and immnuology for avian influenza viruses in poultry. Avian Influenza 2008, 407-451. Blackwell, Ames, IA. D. Swayne (Ed.).
102. Swayne D.E., Kapczynski D. Strategies and challenges for eliciting immunity against avian influenza virus in birds. Immunological Reviews 2008, 225:314-331.
103. Swayne D.E., Slemons R.D. Using mean infectious dose of high- and low-pathogenicity avian influenza viruses originating from wild duck and poultry as one measure of infectivity and adaptation to poultry. Avian Diseases 2008, 52(3):455-460.
104. Swayne D.E., Beck J.R., Mickle T.R. Efficacy of recombinant fowl poxvirus vaccine in protecting chickens against a highly pathogenic Mexican-origin H5N2 avian influenza virus. Avian Diseases 1997, 41(4):910-922.
105. Swayne D.E., Beck J.R., Kinney N. Failure of a recombinant fowl poxvirus vaccine containing an avian influenza hemagglutinin gene to provide consistent protection against influenza in chickens preimmunized with a fowl pox vaccine. Avian Diseases 2000, 44(1):132-137.
106. Swayne D.E., Garcia M., Beck J.R., Kinney N., Suarez D.L. Protection against diverse highly pathogenic H5 avian influenza viruses in chickens immunized with a recombinant fowlpox vaccine containing an H5 avian influenza hemagglutinin gene insert. Vaccine 2000, 18(11/12):1088-1095.
107. Swayne D.E., Perdue M.L., Beck J.R., Garcia M., Suarez D.L. Vaccines protect chickens against H5 highly pathogenic avian influenza in the face of genetic changes in field viruses over multiple years. Veterinary Microbiology 2000, 74(1/2):165-172.
108. Swayne D.E., Beck J.R., Perdue M.L., Beard C.W. Efficacy of vaccines in chickens against highly pathogenic Hong Kong H5N1 avian influenza. Avian Diseases 2001, 45(2):355-365.
109. Swayne D.E., Lee C.W., Spackman E. Inactivated North American and European H5N2 avian influenza virus vaccines protect chickens from Asian H5N1 high pathogenicity avian influenza virus. Avian Pathology 2006, 35(2):141-146.
110. Swayne D.E., Pavade G., Hamilton K., Vallat B., Miyagishima K. Assessment of national strategies for control of high-pathogenicity avian influenza and low-pathogenicity notifiable avian influenza in poultry, with emphasis on vaccines and vaccination. Revue Scientifique et Technique 2011, 30(3):839-870.
111. Tambyah P.A., Wilder-Smith A., Pavlova B.G., Barrett P.N., Oh H.M., Hui D.S., Yuen K.Y., Fritsch S., Aichinger G., Loew-Baselli A., van der Velden M., Maritsch F., Kistner O., Ehrlich H.J. Safety and immunogenicity of two different doses of a Vero cell-derived, whole virus clade 2 H5N1 (A/Indonesia/05/2005) influenza vaccine. Vaccine 2012, 30(2):329-335.
112. Tao P., Luo M., Pan R., Ling D., Zhou S., Tien P., Pan Z. Enhanced protective immunity against H5N1 influenza virus challenge by vaccination with DNA expressing a chimeric hemagglutinin in combination with an MHC class I-restricted epitope of nucleoprotein in mice. Antiviral Research 2009, 81(3):253-260.
113. Taylor J., Weinberg R., Kawaoka Y., Webster R.G., Paoletti E. Protective immunity against avian influenza induced by a fowlpox virus recombinant. Vaccine 1988, 6(6):504-508.
114. Tevethia S.S., Cunningham C.H. Antigenic characterization of infectious bronchitis virus. Journal of Immunology 1968, 100(4):793-798.
115. Tompkins S.M., Zhao Z.S., Lo C.Y., Misplon J.A., Liu T., Ye Z., Hogan R.J., Wu Z., Benton K.A., Tumpey T.M., Epstein S.L. Matrix protein 2 vaccination and protection against influenza viruses, including subtype H5N1. Emerging Infectious Diseases 2007, 13(3):426-435.
116. Toro H., Tang D.C., Suarez D.L., Sylte M.J., Pfeiffer J., Van Kampen K.R. Protective avian influenza in ovo vaccination with non-replicating human adenovirus vector. Vaccine 2007, 25(15):2886-2891.
117. Toro H., Tang D.C., Suarez D.L., Zhang J., Shi Z. Protection of chickens against avian influenza with non-replicating adenovirus-vectored vaccine. Vaccine 2008, 26(21):2640-2646.
118. Tseng L.P., Liang H.J., Deng M.C., Lee K.M., Pan R.N., Yang J.C., Huang Y.Y., Liu D.Z. The influence of liposomal adjuvant on intranasal vaccination of chickens against Newcastle disease. Veterinary Journal 2010, 185(2):204-210.
119. Tseng Y.F., Hu A.Y., Huang M.L., Yeh W.Z., Weng T.C., Chen Y.S., Chong P., Lee M.S. Adaptation of high-growth influenza H5N1 vaccine virus in Vero cells: implications for pandemic preparedness. PLoS ONE 2011, 6(10):e24057.
120. van der Goot J.A., Koch G., de Jong M.C., van Boven M. Quantification of the effect of vaccination on transmission of avian influenza (H7N7) in chickens. Proceedings of the National Academy of Sciences of the United States of America 2005, 102(50):18141-18146.
121. Veits J., Luschow D., Kindermann K., Werner O., Teifke J.P., Mettenleiter T.C., Fuchs W. Deletion of the non-essential UL0 gene of infectious laryngotracheitis (ILT) virus leads to attenuation in chickens, and UL0 mutants expressing influenza virus haemagglutinin (H7) protect against ILT and fowl plague. Journal of General Virology 2003, 84(Pt. (12)):3343-3352.
122. Villarreal C. Avian influenza in Mexico. Revue Scientifique et Technique 2009, 28(1):261-265.
123. Von Dobschuetz, S., Siembieda, J., Kim, M., Pinto, J., Newman, S., 2011. Highly Pathogenic Avian Influenza. Transboundary Animal Diseases Bulliten(37), 21-29.
124. Webster R.G., Taylor J., Pearson J., Rivera E., Paoletti E. Immunity to Mexican H5N2 avian influenza viruses induced by a fowl pox-H5 recombinant. Avian Diseases 1996, 40(2):461-465.
125. Wood J.M., Kawaoka Y., Newberry L.A., Bordwell E., Webster R.G. Standardization of inactivated H5N2 influenza vaccine and efficacy against lethal A/Chicken/Pennsylvania/1370/83 infection. Avian Diseases 1985, 29(3):867-872.
126. Wu Q., Fang L., Wu X., Li B., Luo R., Yu Z., Jin M., Chen H., Xiao S. A pseudotype baculovirus-mediated vaccine confers protective immunity against lethal challenge with H5N1 avian influenza virus in mice and chickens. Molecular Immunology 2009, 46(11/12):2210-2217.
127. Xu K., Ling Z.Y., Sun L., Xu Y., Bian C., He Y., Lu W., Chen Z., Sun B. Broad humoral and cellular immunity elicited by a bivalent DNA vaccine encoding HA and NP genes from an H5N1 virus. Viral Immunology 2011, 24(1):45-56.
128. Zhang W., Xue T., Wu X., Zhang P., Zhao G., Peng D., Hu S., Wang X., Liu X., Liu W. Increase in viral yield in eggs and MDCK cells of reassortant H5N1 vaccine candidate viruses caused by insertion of 38 amino acids into the NA stalk. Vaccine 2011, 29(45):8032-8041.
129. Zhao G., Lin Y., Du L., Guan J., Sun S., Sui H., Kou Z., Chan C.C., Guo Y., Jiang S., Zheng B.J., Zhou Y. An M2e-based multiple antigenic peptide vaccine protects mice from lethal challenge with divergent H5N1 influenza viruses. Virology Journal 2010, 7:9.
130. Zheng L., Wang F., Yang Z., Chen J., Chang H., Chen Z. A single immunization with HA DNA vaccine by electroporation induces early protection against H5N1 avian influenza virus challenge in mice. BMC Infectious Diseases 2009, 9:17.
131. Zhou F., Wang G., Buchy P., Cai Z., Chen H., Chen Z., Cheng G., Wan X.F., Deubel V., Zhou P. A triclade DNA vaccine designed on the basis of a comprehensive serologic study elicits neutralizing antibody responses against all clades and subclades of highly pathogenic avian influenza H5N1 viruses. Journal of Virology 2012, 86(12):6970-6978.
132. Zhou F., Zhou J., Ma L., Song S., Zhang X., Li W., Jiang S., Wang Y., Liao G. High-yield production of a stable Vero cell-based vaccine candidate against the highly pathogenic avian influenza virus H5N1. Biochemical and Biophysical Research Communications 2012, 421(4):850-854.